Back

Tumor-Specific Divergence of Tumor-Associated Macrophage Prognostic Effects Across TCGA Lung and Melanoma Cohorts

Lehrer, S.; Rheinstein, P.

2026-02-24 oncology
10.64898/2026.02.23.26346900 medRxiv
Show abstract

BackgroundTumor-associated macrophages (TAMs) display context-dependent functional polarization, but whether their prognostic impact is consistent across tumor types remains unclear. MethodsWe analyzed RNA-sequencing and clinical data from The Cancer Genome Atlas (TCGA) lung adenocarcinoma (LUAD; n=648), lung squamous carcinoma (LUSC; n=623), and melanoma (SKCM; n=466). Cox proportional hazards models adjusted for age and AJCC stage evaluated per-standard deviation (SD) expression of TAM markers (FOLR2, TREM2) and T-cell markers (CD8A, CXCL9). Cross-histology interaction terms tested divergence between LUAD and LUSC. ResultsIn melanoma, higher FOLR2 (HR 0.87), TREM2 (HR 0.83), CD8A (HR 0.69), and CXCL9 (HR 0.67) independently predicted improved survival. LUAD showed largely neutral macrophage effects. In contrast, LUSC demonstrated an adverse association for FOLR2 (HR 1.28). Interaction analysis confirmed significant divergence for FOLR2 and TREM2 between LUAD and LUSC. ConclusionsTAM-associated prognostic effects reverse by tumor histology, supporting tumor-context-dependent macrophage polarization and informing macrophage-targeted therapeutic strategies.

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

1
Journal for ImmunoTherapy of Cancer
64 papers in training set
Top 0.1%
10.1%
2
JNCI: Journal of the National Cancer Institute
16 papers in training set
Top 0.1%
10.1%
3
Clinical Cancer Research
58 papers in training set
Top 0.2%
6.8%
4
Nature Communications
4913 papers in training set
Top 29%
6.3%
5
JNCI Cancer Spectrum
10 papers in training set
Top 0.1%
4.0%
6
Annals of Oncology
13 papers in training set
Top 0.2%
3.1%
7
Cancers
200 papers in training set
Top 2%
3.1%
8
JAMA Network Open
127 papers in training set
Top 1%
3.1%
9
Scientific Reports
3102 papers in training set
Top 44%
2.7%
10
PLOS ONE
4510 papers in training set
Top 45%
2.6%
50% of probability mass above
11
European Journal of Cancer
10 papers in training set
Top 0.1%
2.6%
12
British Journal of Cancer
42 papers in training set
Top 0.6%
2.1%
13
American Journal of Respiratory and Critical Care Medicine
39 papers in training set
Top 0.4%
1.9%
14
Journal of Clinical Investigation
164 papers in training set
Top 2%
1.9%
15
Immunology
29 papers in training set
Top 0.4%
1.8%
16
Frontiers in Oncology
95 papers in training set
Top 2%
1.7%
17
Molecular Oncology
50 papers in training set
Top 0.4%
1.7%
18
International Journal of Cancer
42 papers in training set
Top 0.6%
1.7%
19
Frontiers in Immunology
586 papers in training set
Top 4%
1.7%
20
Cancer Immunology, Immunotherapy
11 papers in training set
Top 0.2%
1.3%
21
Nature Cancer
35 papers in training set
Top 1.0%
1.2%
22
OncoImmunology
22 papers in training set
Top 0.3%
1.2%
23
Brain, Behavior, & Immunity - Health
27 papers in training set
Top 0.3%
1.2%
24
Journal of Translational Medicine
46 papers in training set
Top 2%
1.2%
25
Cancer Epidemiology, Biomarkers & Prevention
17 papers in training set
Top 0.5%
1.1%
26
EClinicalMedicine
21 papers in training set
Top 0.6%
0.9%
27
Cancer Cell
38 papers in training set
Top 2%
0.9%
28
Cancer Medicine
24 papers in training set
Top 1%
0.9%
29
Cancer Letters
32 papers in training set
Top 0.7%
0.8%
30
PeerJ
261 papers in training set
Top 14%
0.8%